Literature DB >> 26763750

Infections due to Elizabethkingia meningoseptica in critically injured trauma patients: a seven-year study.

N Rastogi1, P Mathur2, A Bindra3, K Goyal3, N Sokhal3, S Kumar4, S Sagar4, R Aggarwal3, K D Soni3, V Tandon5.   

Abstract

Elizabethkingia meningoseptica is an infrequent cause of hospital-acquired infections. The clinical and microbiological profiles of infections due to E. meningoseptica over a seven-year period at a Level-I trauma centre are reported in this study. Medical records of patients from whose clinical samples E. meningoseptica was isolated on more than one occasion were reviewed. A total of 21 cases were observed during the study, 16 (76.2%) of which exhibited multidrug resistance. The observed in-hospital mortality rate was 47.6%. A high index of clinical suspicion and effective detection of E. meningoseptica in clinical samples are requisite for improved clinical outcome.
Copyright © 2015 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bronchoalveolar lavage; Elizabethkingia meningoseptica; Immunocompetent; Intensive care unit; Multidrug resistant; Trauma

Mesh：

Substances：

Year:  2015        PMID： 26763750     DOI： 10.1016/j.jhin.2015.07.008

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


  8 in total

1.  Multidrug resistant Elizabethkingia meningoseptica bacteremia - Experience from a level 1 trauma centre in India.

Authors:  Aishwarya Govindaswamy; Vijeta Bajpai; Vivek Trikha; Samarth Mittal; Rajesh Malhotra; Purva Mathur
Journal:  Intractable Rare Dis Res       Date:  2018-08

2.  Draft Genome Sequence of Elizabethkingia anophelis Strain EM361-97 Isolated from the Blood of a Cancer Patient.

Authors:  Jiun-Nong Lin; Chih-Hui Yang; Chung-Hsu Lai; Yi-Han Huang; Hsi-Hsun Lin
Journal:  Genome Announc       Date:  2016-10-27

3.  Challenges in the identification of Chryseobacterium indologenes and Elizabethkingia meningoseptica in cases of nosocomial infections and patients with cystic fibrosis.

Authors:  É B de Carvalho Filho; F A L Marson; C E Levy
Journal:  New Microbes New Infect       Date:  2017-09-13

4.  Invasive paediatric Elizabethkingia meningoseptica infections are best treated with a combination of piperacillin/tazobactam and trimethoprim/sulfamethoxazole or fluoroquinolone.

Authors:  J C Chan; C Y Chong; K C Thoon; N W S Tee; M Maiwald; J C M Lam; R Bhattacharya; S Chandran; C F Yung; N W H Tan
Journal:  J Med Microbiol       Date:  2019-06-14       Impact factor: 2.472

Review 5.  Elizabethkingia Infections in Humans: From Genomics to Clinics.

Authors:  Jiun-Nong Lin; Chung-Hsu Lai; Chih-Hui Yang; Yi-Han Huang
Journal:  Microorganisms       Date:  2019-08-28

6.  Risk Factors for Mortality in Patients with Elizabethkingia Infection and the Clinical Impact of the Antimicrobial Susceptibility Patterns of Elizabethkingia Species.

Authors:  Hye Seong; Jung Ho Kim; Jun Hyoung Kim; Woon Ji Lee; Jin Young Ahn; Nam Su Ku M D; Jun Yong Choi; Joon Sup Yeom; Young Goo Song; Su Jin Jeong
Journal:  J Clin Med       Date:  2020-05-12       Impact factor: 4.241

7.  Neonatal Meningitis with Septicemia by Elizabethkingia meningoseptica : A Case Report.

Authors:  Neetha S Murthy; Sowmya G Shivappa; A Tejashree; Krishna M V S Karthik; R Deepashree
Journal:  J Lab Physicians       Date:  2022-02-09

8.  Epidemiological, clinical, and laboratory features of patients infected with Elizabethkingia meningoseptica at a tertiary hospital in Hefei City, China.

Authors:  Yajuan Li; Tingting Liu; Cuixiao Shi; Bo Wang; Tingting Li; Ying Huang; Yuanhong Xu; Ling Tang
Journal:  Front Public Health       Date:  2022-09-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.